Imugene strikes deals with Merck and Pfizer over manufacture
MELBOURNE: Paul Hopper-chaired biotech Imugene is taking further steps to validate its cancer ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
